Competition Commission of India (CCI) approves the proposed investments by Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund, Mudhra Lifesciences Private Limited, Mudhra Pharmacorp LLP Kotak Strategic Situations India Fund II and Kotak Alternate Asset Managers Limited for acquisition of 100% of the equity shares of Tianish Laboratories Private Limited by Matrix Pharma Private Limited

Competition Commission of India (CCI) approves the proposed investments by Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund, Mudhra Lifesciences Private Limited, Mudhra Pharmacorp LLP Kotak Strategic Situations India Fund II and Kotak Alternate Asset Managers Limited for acquisition of 100% of the equity shares of Tianish Laboratories Private Limited by Matrix Pharma Private Limited

Date	28/05/2024
Press Release (97.53 KB)